Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 26

Cited In for PubMed (Select 11978687)

1.

Diabetic foot syndrome and corneal subbasal nerve plexus changes in congolese patients with type 2 diabetes.

Zhivov A, Peschel S, Schober HC, Stachs O, Baltrusch S, Bambi MT, Kilangalanga J, Winter K, Kundt G, Guthoff RF.

PLoS One. 2015 Mar 26;10(3):e0119842. doi: 10.1371/journal.pone.0119842. eCollection 2015.

2.
3.

Epidemiological aspects of atherosclerosis in patients treated for acute atherothrombosis of extremity arteries.

Rustempasic N, Totic D, Djedovic M, Rustempasic M, Malesic N.

Med Arch. 2014 Oct;68(5):329-31. doi: 10.5455/medarh.2014.68.329-331. Epub 2014 Oct 15.

4.

Evaluation of cardiovascular risk factors in women with uterine leimyoma: is there a link with atherosclerosis?

Sivri N, Yalta T, Sayın C, Yalta K, Ozpuyan F, Taştekin E, Yetkin E.

Balkan Med J. 2012 Sep;29(3):320-3. doi: 10.5152/balkanmedj.2012.002. Epub 2012 Sep 1.

5.

Type 2 diabetes and cardiovascular disease: Have all risk factors the same strength?

Martín-Timón I, Sevillano-Collantes C, Segura-Galindo A, Del Cañizo-Gómez FJ.

World J Diabetes. 2014 Aug 15;5(4):444-70. doi: 10.4239/wjd.v5.i4.444. Review.

6.

Risk factors for incident peripheral arterial disease in type 2 diabetes: results from the Bypass Angioplasty Revascularization Investigation in type 2 Diabetes (BARI 2D) Trial.

Althouse AD, Abbott JD, Forker AD, Bertolet M, Barinas-Mitchell E, Thurston RC, Mulukutla S, Aboyans V, Brooks MM; BARI 2D Study Group.

Diabetes Care. 2014;37(5):1346-52. doi: 10.2337/dc13-2303. Epub 2014 Mar 4.

7.

Reducing resistance to treatment, through group intervention, improves clinical measurements in patients with type 2 diabetes.

Valinsky L, Mishali M, Endevelt R, Preiss R, Dopelt K, Heymann AD.

BMC Endocr Disord. 2013 Dec 28;13:61. doi: 10.1186/1472-6823-13-61.

8.

Evaluation of clinical activity and safety of Daflon 500 mg in type 2 diabetic female patients.

Rizk SM, Sabri NA.

Saudi Pharm J. 2009 Jul;17(3):199-207. doi: 10.1016/j.jsps.2009.08.008. Epub 2009 Aug 7.

9.

The effect of exercise training on ankle-brachial index in type 2 diabetes.

Barone Gibbs B, Dobrosielski DA, Althouse AD, Stewart KJ.

Atherosclerosis. 2013 Sep;230(1):125-30. doi: 10.1016/j.atherosclerosis.2013.07.002. Epub 2013 Jul 14.

10.

Favorable effects of insulin sensitizers pertinent to peripheral arterial disease in type 2 diabetes: results from the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial.

Althouse AD, Abbott JD, Sutton-Tyrrell K, Forker AD, Lombardero MS, Buitrón LV, Pena-Sing I, Tardif JC, Brooks MM; BARI 2D Study Group.

Diabetes Care. 2013 Oct;36(10):3269-75. doi: 10.2337/dc12-2265. Epub 2013 Jun 4.

11.

Criticial limb ischemia: epidemiology.

Davies MG.

Methodist Debakey Cardiovasc J. 2012 Oct-Dec;8(4):10-4. Review.

12.

Associations between conventional cardiovascular risk factors and risk of peripheral artery disease in men.

Joosten MM, Pai JK, Bertoia ML, Rimm EB, Spiegelman D, Mittleman MA, Mukamal KJ.

JAMA. 2012 Oct 24;308(16):1660-7. doi: 10.1001/jama.2012.13415.

13.

Glucose control and cardiovascular outcomes: reorienting approach.

Khardori R, Nguyen DD.

Front Endocrinol (Lausanne). 2012 Aug 29;3:110. doi: 10.3389/fendo.2012.00110. eCollection 2012.

14.

Glycosylated hemoglobin in relationship to cardiovascular outcomes and death in patients with type 2 diabetes: a systematic review and meta-analysis.

Zhang Y, Hu G, Yuan Z, Chen L.

PLoS One. 2012;7(8):e42551. doi: 10.1371/journal.pone.0042551. Epub 2012 Aug 9. Review.

15.

Correlation between peripheral arterial disease and coronary artery disease using ankle brachial index-a study in Indian population.

Sarangi S, Srikant B, Rao DV, Joshi L, Usha G.

Indian Heart J. 2012 Jan-Feb;64(1):2-6. doi: 10.1016/S0019-4832(12)60002-9. Epub 2012 Mar 26.

16.

Progression of diabetic retinopathy correlated with muscle perfusion disturbances of the lower limbs, with clinically important diagnostic recommendations.

Tryniszewski W, Gadzicki M, Maziarz Z, Kuśmierczyk J, Goś R, Rysz J, Banach M.

Arch Med Sci. 2010 Dec;6(6):904-11. doi: 10.5114/aoms.2010.19300. Epub 2010 Dec 29.

17.

Plasma osteoprotegerin is related to carotid and peripheral arterial disease, but not to myocardial ischemia in type 2 diabetes mellitus.

Poulsen MK, Nybo M, Dahl J, Hosbond S, Poulsen TS, Johansen A, Høilund-Carlsen PF, Beck-Nielsen H, Rasmussen LM, Henriksen JE.

Cardiovasc Diabetol. 2011 Aug 12;10:76. doi: 10.1186/1475-2840-10-76.

18.

Prevalence of neuropathy and peripheral arterial disease and the impact of treatment in people with screen-detected type 2 diabetes: the ADDITION-Denmark study.

Charles M, Ejskjaer N, Witte DR, Borch-Johnsen K, Lauritzen T, Sandbaek A.

Diabetes Care. 2011 Oct;34(10):2244-9. doi: 10.2337/dc11-0903. Epub 2011 Aug 4.

19.

Effects of exercise on VLDL-triglyceride oxidation and turnover.

Sondergaard E, Rahbek I, Sørensen LP, Christiansen JS, Gormsen LC, Jensen MD, Nielsen S.

Am J Physiol Endocrinol Metab. 2011 May;300(5):E939-44. doi: 10.1152/ajpendo.00031.2011. Epub 2011 Mar 8.

20.

The 25-year cumulative incidence of lower extremity amputations in people with type 1 diabetes.

Sahakyan K, Klein BE, Lee KE, Myers CE, Klein R.

Diabetes Care. 2011 Mar;34(3):649-51. doi: 10.2337/dc10-1712. Epub 2011 Jan 27.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk